United Therapeutics Corporation (UTHR) News
Filter UTHR News Items
UTHR News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
UTHR News Highlights
- For UTHR, its 30 day story count is now at 16.
- Over the past 20 days, the trend for UTHR's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- TOP, MD and BIO are the most mentioned tickers in articles about UTHR.
Latest UTHR News From Around the Web
Below are the latest news stories about UNITED THERAPEUTICS CORP that investors may wish to consider to help them evaluate UTHR as an investment opportunity.
15 Undervalued Defensive Stocks For 2024In this article, we discuss the 15 undervalued defensive stocks for 2024. To skip the detailed overview of the market and defensive stocks, go directly to the 5 Undervalued Defensive Stocks For 2024. Defensive stocks are shares of companies that remain relatively stable during economic downturns as opposed to cyclical stocks. Defensive stocks usually outperform […] |
Director Nilda Mesa Sells Shares of United Therapeutics CorpOn December 19, 2023, Director Nilda Mesa sold 605 shares of United Therapeutics Corp (NASDAQ:UTHR), according to a recent SEC Filing. |
Insider Sell: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)United Therapeutics Corp (NASDAQ:UTHR) has recently witnessed an insider sell that has caught the attention of investors and market analysts. |
Investors in United Therapeutics (NASDAQ:UTHR) have seen stellar returns of 143% over the past five yearsWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose... |
Catalent (CTLT) Up 4.1% Since Last Earnings Report: Can It Continue?Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Here's Why United Therapeutics (UTHR) is a Strong Momentum StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
Insider Sell Alert: Director Christopher Causey Sells 3,000 Shares of United Therapeutics Corp ...United Therapeutics Corp (NASDAQ:UTHR) has recently witnessed an insider sell that has caught the attention of investors and market analysts. |
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn., December 13, 2023--United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per |
United Therapeutics and Miromatrix Medical Announce Successful Tender OfferSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn., December 12, 2023--United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. ("Merger Sub"), a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon t |
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |